Spirometer Market Intelligence, Prescriptive Research, Execute Growth Opportunities

A spirometer is used to help a patient who is having trouble breathing and is not getting enough oxygen. Patients with respiratory illnesses such asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome require COPD and asthma diagnostic and monitoring devices. Furthermore, rising geriatric populations, tobacco use, allergens, and air pollution all contribute to an increase in the prevalence of respiratory disorders, which drives the worldwide spirometer market.

The global spirometer market is estimated to grow during the forecast period, owing to factors such as innovation, technological advancements, and advancements of spirometers. The World Health Organization (WHO) reported that asthma affects around 300 million people worldwide, and 250,000 have died due to asthma globally. In 2019, approximately 65 million people had COPD across the globe; among which around 16 million Americans had COPD and the number is estimated to grow in the future. Spirometers are being extensively used for treatment, diagnosis, monitoring, and controlling respiratory disorders. Rise in prevalence of respiratory diseases and increase in adoption of smoking & alcohol consumption are the primary factors fueling the spirometer market growth.

The table-top category is expected to have the highest share during the projected period. Throughout the projected period, this segment is expected to maintain its leading position. Furthermore, advancements in diagnostic gadgets have not only made them more convenient to use, but have also made them portable and automatic. Furthermore, these developments aid clinical researchers and clinicians in their research. All of these factors are projected to drive market expansion throughout the forecast period.

In terms of technology, the flow measurement segment accounted for the majority of the market in 2019. This is due to the growing use of flow measurement spirometers in pulmonary function testing applications for the clinical diagnosis of COPD and asthma. These are smaller and more portable, computerised, and aid in the prevention of infections. Thus, flow measurement technology is more desirable than volume measurement technology in spirometers and is predicted to increase at a faster rate.